The treatment for burns


(57) Abstract:

The invention relates to medicine, in particular to pharmacology, concerns the creation of funds for the treatment of burns 1, II, IIIa and IIIB degree. The treatment for burns contains olive oil, beeswax and organic lead salt at the ratio of ingredients, wt. %: wax 14,0-30,0; organic lead salt 0,05-0,11; olive oil else. The treatment for burns is a radical treatment for at defeat 2/3 % of the body surface. 1 C. p. F.-ly.

The invention relates to medicine, in particular to pharmacology, and can be used as a treatment for burns I, II, IIIA and IIIB degree.

Known healing ointment (U.S. Patent N 4883664, A 61 K 35/78, 31/19, 1993).

Ointment suitable for topical treatment of various burns caused by boiling water or steam and contains about 2. including olive oil, about 1. including beeswax, about 4. including anhydrous lanolin and trace amount of pine tar.

It is also known remedy for treating burns, infections, wounds, ulcers, skin lesions, which comprises as active ingredients the calculated amount of silver or of mineral or organic salts and antibiotics, such as apologizin, t SU 1805952 A 61 K 9/06, 1993 ), which is an ointment that as fat product contains vegetable oil, as a bee product - wax, and as an antiseptic, rivanol. The developed tool has a high penetration in the tissue and used for the successful treatment of trophic ulcers and burns II and III. This recovery occurred within 12 to 15 days.

The objective of the invention is to increase the pharmacological activity of drugs for local treatment of burns.

The task was achieved through the creation of an ointment containing vegetable oil, such as olive wax, and as the active ingredient of the drug lead, in the following ratio of ingredients, wt.%:

Wax - 14,0 - 30,0

Preparation of lead - 0,05 - 0,11

Vegetable oil - Rest

As a drug lead the product contains organic salts, in particular the acetate of lead.

For preparation of ointment uses olive oil VFS 42-1776-87, wax GOST 21179-90 and acetate of lead (the register. ID 67/554/204).

Lead acetate is a crystalline solid with a weak acetic smell. The drug is soluble in 2.5 g of cold and 0.5 g of boiling water (N. D. Mash solutions as binders in inflammatory diseases of the skin and mucous membranes.

The ointment is prepared as follows: vegetable oil is brought to a boil in a steam bath, after which it add the wax to dissolve, then enter the acetate of lead with continuous stirring. After adding lead acetate to the melt tank with cool ointment on system flow cooling with simultaneous flow mixing until you obtain the consistency of the ointment and complete cooling. Keep ointment need in a glass container in a cool place. Shelf life - 2 years.

Application of ointments: before use, means the wound should be treated with antiseptic solution, such as reunala, then apply a thin layer of ointment on undyed cotton cloth and apply with capture 2-3 cm nearby healthy tissues and bandaging. Burns a large square bandage change carried out every 4 hours, with a small area once a day.

therapeutic properties of the tools are manifested in healing and bactericidal action.

The possible mechanism of action of the product is that the drug lead, in particular the acetate of lead, having astringent properties, prevents the development proliferative-exudative phase, which speeds up the Gah.

Beeswax has antibacterial properties, preventing infection of burn surface.

Olive oil promotes epithelialization.

Example 1. Patient C. for 1.5 years. Got the burn I tbsp. boiling water, area of 95%. Used the opening of bubbles and specific treatment. Immediately after applying the ointment significant reduction in pain. The ointment was applied 6 times a day. Once the operation has been performed how agressively to debride in the neck and groin (ointment in these places was not used). Complete recovery after 2 weeks without the formation of post-burn contractures and scars.

Example 2. Patient N. 42. Received burns to the face and hands IIIB tbsp. melted tar 15%. Conducted traditional treatment in the hospital.

After applying ointment 2 times a day, on the background of specific treatment, complete healing of 1.5 weeks, without the formation of keloid scars. Surgical intervention was not performed.

Example 3. The patient And. 2 years. Got chemical burns on the face of caustic soda. Damage to the lips, oral mucosa, cheek. The treatment of outpatients with exceptional use of ointments. Immediately after applying the ointment significant reduction in pain. Full wisdo the th flame II senior Use only the ointment, treatment on an outpatient basis. Blistering occurred. Full recovery 1.5 weeks.

Example 5. Patient R. 32 years. Electromag right half of the body. Inpatient treatment with the use of conventional therapy. As external funds were used ointment 3 times a day. Pain was not. How agressively to debride was not made. Full recovery after 3 weeks without scarring.

Just treated 51 people.

Of them: burn Art. I - 10, burn Art. II - 16 burn IIIA - 14, burn IIIB - 5, a chemical burn 4 electromag - 2.

Ineffective treatment.

The treatment time of 1.5-3 weeks.

The following are specific examples of the preparation of the ointment for the treatment of burns.

Example 6. Olive oil, taken in an amount 799,3 g, brought to boiling on the steam bath, then it is added to 200.0 g of beeswax until dissolved. Then in the resulting homogeneous mixture is injected under continuous stirring, 0.7 g of lead acetate. Further, the container of ointment cooled, Packed and sent to storage for further use.

Example 7. Analogously to example 5 is prepared max, the ointment is a radical treatment for burns even if the affected 2/3% of the body surface. Burns third degree, if the ointment slice apply to damaged areas, bubbles with serenitybase content does not appear. Promotes ointment and also rapid rejection of the scab and the development of granulation tissue. Post-burn scar when its use becomes less dense. Keloid scars are not visible.

If you did not apply surgical treatment, there is no scar formation after burn contractures.

1. Means for treatment of burns, containing wax and vegetable oil, characterized in that it additionally contains an organic salt of lead in the following ratio of ingredients, wt.%:

Wax - 14,0-30,0

Organic lead salt - 0,05-0,11

Vegetable oil - Rest

2. Means under item 1, characterized in that as the organic salts of lead it contains lead acetate.


Same patents:

The invention relates to sorbic acid or its salts, containing low concentrations of manganese ion (Mn++) as stabilizer

The invention relates to new compositions of chemical compositions, namely the composition of natural amino acids and trace elements, which has anti-tumor and antihypoxic activity, and may find application in medicine

The invention relates to clinical medicine and aims to reduce the toxic effects of high doses of vitamin D2in children with vitamin D-resistant rickets

The invention relates to medicine, in particular, to pharmacology
The invention relates to medicine, namely to dentistry

FIELD: medicine, narcology.

SUBSTANCE: one should detect satisfaction insufficiency syndrome due to performing genetic analysis by the presence of, at least, one of the genes coding the exchange of neuromediators being the constituents of human satisfaction system. One should compensate satisfaction insufficiency due to performing, at least, one complex of physical exercises. Moreover, in case of availability of pathological gene allele of dopamine D2 receptor and/or protein gene of reverse dopamine capture in patient one should apply the complex of physical exercises including those to provide sedative effect, and in case of availability of pathological gene allele of dopamine-beta-hydroxylase protein one should apply the complex of physical exercises including those that induce an activating effect. In case of availability of pathological gene allele of dopamine D2 receptor and/or protein gene of reverse dopamine capture one should apply additional food biologically active additives based upon amino acids being the precursors of neuromediators, such as taurine, D-, L-phenylalanine in combination with 5-hydroxytryptophan, hypericin and vitamin B6, and in case of pathological gene allele of dopamine-beta-hydroxylase protein one should additionally apply food biologically active additives based upon amino acids being the precursors of neuromediators, such as: taurine, tyrosine and/or dimethylaminoethanol, lecithin and group B-vitamins. The present innovation enables to take into account pathological disease mechanism.

EFFECT: higher efficiency of prophylaxis.

14 cl, 5 ex

FIELD: medicine, cardiology.

SUBSTANCE: the suggested method should be performed at the background of medicinal therapy with preparations out of statins group, tevetene, polyoxidonium and conducting seances of plasmapheresis by removing 800 ml plasma twice weekly with N 5 due to additional intramuscular injection of immunophan 0.005%-1.0 with N 10 and fluimucyl 300 mg intravenously daily with N 5-10, total course of therapy lasts for 2 mo. The method provides modulation of leukocytic functional activity, moreover, due to altered cytokine profile and, thus, through disintegration of protein-lipid complexes participating in the development of atherosclerotic platelets.

EFFECT: higher efficiency of therapy.

3 ex

FIELD: medicine, combustiology, resuscitation.

SUBSTANCE: during the first 2 d since the moment of trauma one should intravenously inject infusion solution of vasaprostan additionally to conventional anti-shock therapy at 1 mcg/kg patient's body weight daily. The present innovation favors to normalize capillary walls' tonicity, decrease their permeability and improve the values of blood hemoconcentration and viscosity.

EFFECT: higher efficiency of correction.

1 ex, 1 tbl

FIELD: organic chemistry, medicine, immunology.

SUBSTANCE: invention proposes applying 2,4-dichlorophenoxyacetic acid tris-(2-oxyethyl)-ammonium salt as an immunomodulating agent. The newly found properties provide the development on its base medicinal agents for treatment of inflammatory, autoimmune and lymphoproliferative diseases.

EFFECT: valuable medicinal properties of agent, expanded assortment of agents of indicated designation.

4 tbl, 4 ex

FIELD: medicine, oncology, amino acids.

SUBSTANCE: invention relates, in particular, to the development of an antitumor preparation based on natural substances. Invention relates to an amino acid preparation comprising at least one modified essential amino acid obtained by treatment of amino acid by ultraviolet radiation (UV) at wavelength 250-350 nm for 12-80 h at temperature 15-30oC or with ozone at temperature 15-25oC. The modified amino acid has no toxicity for health cells. Also, invention relates to a method for preparing such preparation. Invention provides the development of an antitumor preparation based on modified amino acids and expanded assortment of antitumor preparations being without cytotoxicity for normal cells.

EFFECT: valuable medicinal antitumor properties of preparation.

8 cl, 4 tbl, 2 dwg, 4 ex

FIELD: medicine, oncology.

SUBSTANCE: the method deals with polychemotherapy and is fulfilled by the following technique: it is necessary to carry out blood sampling in these patients at the quantity of 25 ml: during the 1st d of polychemotherapy one should incubate 5 ml autoblood with 50 mg/sq. m metothrexate, during the 2nd, 3d, 4th and 5th d one should incubate per 5 ml autoblood with 15 mg/sq. m bleomycin daily in thermostat at 37 C for 30 min, carry out application anesthesia and introduce chemopreparations upon autoblood into endonasal tumor component or alternate intratumor introduction of chemopreparations upon autoblood at introducing them into maxillary antrum if it is affected with tumor process. The method provides local concentration and decreased toxicity of chemopreparations due to their intratumor introduction upon autoblood.

EFFECT: higher efficiency of therapy.

1 ex, 1 tbl

FIELD: organic chemistry, medicine.

SUBSTANCE: invention relates to compounds designated for applying in photochemotherapy or diagnosis and indicated compounds represent 5-aminolevulinic acid aryl-substituted esters, their derivatives or pharmaceutically acceptable salts. In particular, invention provides preparing compounds of the general formula (I): R

N-CH2COCH2CH2CO-OR1 wherein R1 represents aryl-substituted C1-alkyl group, preferably C1-alkyl group substituted with non-heteroaromatic aryl wherein indicated group aryl is substituted group, and especially preferable this radical is substituted with one or more alkyl groups (for examples, (C1-C2)-alkyl), alkoxy- (for example, methoxy-) groups, fluorine, chlorine atoms, nitro- or trifluoromethyl groups; R2 being each of that can be similar or different represents hydrogen atom or alkoxycarbonyloxy-; indicated alkyl group is broken optionally with one or more groups: -O-, -NR3-, -S- or -PR3- wherein R3 represents hydrogen atom or (C1-C6)-alkyl group, and their salts for applying in diagnosis and photochemotherapy of injures and disorders of internal and external surfaces of body, and products and sets for realization of this invention also.

EFFECT: valuable medicinal properties of compounds.

18 cl, 17 dwg, 2 tbl, 3 ex

FIELD: polymer materials in medicine.

SUBSTANCE: aqueous solution according to invention contains 0.05-0.11 mole/L oxalic acid and 0.02-0.17 mole/L alkali metal salt(s). Treatment of polymethylmethacrylate materials with such solution allows complete removal of residual monomer without alteration of molecular mass and supramolecular structure of polymer material.

EFFECT: reduced risk of rejection of implants and improved mechanical and optical properties thereof.

1 tbl, 3 ex

FIELD: medicine.

SUBSTANCE: method involves carrying out analysis of clinical manifestations in patients having satisfaction deficiency syndrome. Clinical manifestations like obsessive compulsive disorders occurring, physical training exercises acting upon visceral organs as a result of abdominal wall muscle and inferior and superior small pelvis diaphragm muscle contraction. Clinical manifestations like irritation and aggressiveness being observed, physical training exercises like slow diaphragm-type breathing with deep muscle relaxation or alternating hyperventilation and deep diaphragm-type breathing are to be done. Clinical manifestations like hyperactivity taking place, physical dynamic exercises causing activating action are done in combination with slow deep breathing. Clinical manifestations like emotional disorders being observed, physical training exercises causing sedative action are applied. The exercises are based on alternating muscle and tendon extension and following relaxation. Dietetic low hydrocarbon content nutrition is additionally applied with one of the following diets: low hydrocarbon content diet having animal proteins and saturated with fat, or vegetarian diet having mainly vegetable proteins, moderate hydrocarbon content and large amount of vegetable fibers, or ketogenic diet being protein-and-fat diet containing large amount of fat with fatty acids like triglycerides of chain having not more than 12 carbomers.

EFFECT: enhanced effectiveness of prophylaxis and correction procedures.

11 cl

FIELD: organic chemistry, medicine, pharmacy.

SUBSTANCE: invention relates to a form with reduced size of particles of the compound (S)-2-ethoxy-3-[4-(2-{4-methanesulfonyloxyphenyl}ethoxy)phenyl]propanoic acid described by the formula (I)

or its pharmaceutically acceptable salt or any solvate. Above said compound is useful in treatment of metabolic disorders, such as insulin resistance syndrome determined as reduced sensitivity to insulin effect. Also, invention relates to pharmaceutical compositions containing form with reduced size of particles of this compound or its pharmaceutically acceptable salt or their solvate as an active component, and to methods for preparing form with reduced size of particles of this compound or its pharmaceutically acceptable salt.

EFFECT: improved preparing methods, valuable medicinal properties of compound.

12 cl, 5 ex